Screener
TG Therapeutics TGTX Other Selling General And Administrative Expense
Other Selling General And Administrative Expense at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherSellingGeneralAndAdministrativeExpense.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's other selling general and administrative expense?
- TG Therapeutics (TGTX) reported other selling general and administrative expense of $62.33M in Q2 2026.
- How has TG Therapeutics's other selling general and administrative expense changed year-over-year?
- TG Therapeutics's other selling general and administrative expense increased by 43.1% year-over-year, from $43.54M to $62.33M.
- What is the long-term trend for TG Therapeutics's other selling general and administrative expense?
- Over 4 years (2021 to 2025), TG Therapeutics's other selling general and administrative expense has grown at a 19.3% compound annual growth rate (CAGR), from $90.86M to $183.98M.
- What does other selling general and administrative expense mean?
- Other Selling General And Administrative Expense as reported by TG Therapeutics, Inc..
Ask your AI about TG Therapeutics's other selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude